Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here? (Q88262803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Winette T A van der Graaf

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

1 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

706-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

22 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930330-3

7 January 2021

A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930330-3

7 January 2021

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930330-3

7 January 2021

High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930330-3

7 January 2021

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930330-3

7 January 2021

Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930330-3

7 January 2021

10.1016/S1470-2045(17)30330-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28593841%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference